Form 4 for DGX Quest Diagnostics
Accepted 2021-12-01 00:00:00 ET · period of report 2021-11-29 · accession 0001022079-21-000146 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-01 | 2021-11-29 | DGX | Doherty Catherine T. | SVP, Group Exec. Clin. Fran | M - OptEx | $95.80 | +37.6K | 106.3K | +55% | +$3.60M |
| DM | 2021-12-01 | 2021-11-29 | DGX | Doherty Catherine T. | SVP, Group Exec. Clin. Fran | S - Sale+OE | $156.81 | -37.6K | 83.3K | -31% | -$5.89M |
| D | 2021-12-01 | 2021-11-29 | DGX | Doherty Catherine T. | SVP, Group Exec. Clin. Fran | M - OptEx | $95.80 | -37.6K | 0 | -100% | -$3.60M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-29 | M | A | 37,565 | $95.80 | 106,294 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-29 | S | D | 300 | $153.38 | 105,994 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $153.21 to $153.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2021-11-29 | S | D | 3,250 | $154.79 | 102,744 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $154.21 to $155.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2021-11-29 | S | D | 14,575 | $157.53 | 68,729 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $157.27 to $158.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2021-11-29 | S | D | 3,532 | $155.77 | 99,212 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $155.26 to $156.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2021-11-29 | S | D | 15,908 | $156.86 | 83,304 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $156.27 to $157.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Derivative | Non-Qualifed Stock Option (right to buy) | 2021-11-29 | M | D | 37,565 | $95.80 | 0 | D | $95.80 · — to 2027-02-21 | 37,565 Common Stock | (F8) The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020. |